Drug Shortage Report for SANDOZ IRBESARTAN HCT
| Report ID | 73144 |
| Drug Identification Number | 02337428 |
| Brand name | SANDOZ IRBESARTAN HCT |
| Common or Proper name | IRBESARTAN HCT |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE IRBESARTAN |
| Strength(s) | 12.5MG 150MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-10-29 |
| Estimated end date | 2020-07-10 |
| Actual end date | 2020-07-03 |
| Shortage status | Resolved |
| Updated date | 2020-07-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v38 | 2020-07-20 | French | Compare |
| v37 | 2020-07-20 | English | Compare |
| v36 | 2020-06-08 | French | Compare |
| v35 | 2020-06-08 | English | Compare |
| v34 | 2020-05-11 | French | Compare |
| v33 | 2020-05-11 | English | Compare |
| v32 | 2020-05-04 | French | Compare |
| v31 | 2020-05-04 | English | Compare |
| v30 | 2020-04-06 | French | Compare |
| v29 | 2020-04-06 | English | Compare |
| v28 | 2020-03-30 | French | Compare |
| v27 | 2020-03-30 | English | Compare |
| v26 | 2020-02-15 | French | Compare |
| v25 | 2020-02-15 | English | Compare |
| v24 | 2020-01-08 | French | Compare |
| v23 | 2020-01-08 | English | Compare |
| v22 | 2019-12-10 | French | Compare |
| v21 | 2019-12-10 | English | Compare |
| v20 | 2019-11-18 | French | Compare |
| v19 | 2019-11-18 | English | Compare |